Medical Research News

RSS

New score predicts thrombosis risk in hospitalized pancreatitis patients

Professor Julia Mayerle and colleagues from LMU University Hospital Munich have developed an admission-based score intended to identify pancreatitis patients more likely to be diagnosed with thrombosis during hospitalization.

28 Oct 2026

Engineered albumin could lead to needle-free, long-lasting protein medicines

Protein-based medicines have transformed the treatment of many diseases, but they often come with a limitation: they must be injected, sometimes repeatedly, because they are rapidly cleared from the bloodstream.

28 Oct 2026

Plant and animal proteins show opposite effects on testosterone levels

Higher animal protein intake was associated with lower blood testosterone levels, while higher plant protein intake was associated with higher levels, according to a new study from the University of Eastern Finland.

28 Oct 2026

Review highlights essential neurological considerations for gender dysphoria care

Gender dysphoria involves distress caused by a mismatch between a person's gender identity and sex assigned at birth.

28 Oct 2026

Overcoming cancer stigma requires policy changes and public education

Cancer-related discrimination arises from long-lasting cultural and institutional misconceptions, with significant impacts on every part of a person's quality of life and health – and Flinders University researchers say it requires coordinated policy, legal, institutional and public education responses for change to occur.

28 Oct 2026

DEBRA research invests in Topadur to advance small-molecule therapies for dystrophic Epidermolysis bullosa

DEBRA Research gGmbH, a global non-profit organization dedicated to advancing research and drug development for Epidermolysis bullosa (EB), and Topadur Pharma AG, a Swiss clinical-stage biopharmaceutical company, today announced an investment by DEBRA Research in Topadur to support a preclinical program exploring a new treatment approach for dystrophic Epidermolysis bullosa (DEB). DEB is one of the more severe forms of EB, characterized by extremely fragile skin and progressive, debilitating complications.

28 Oct 2026

Adalvo expands biosimilars portfolio through acquisition of romiplostim biosimilar program from Enzene

Adalvo today announced the acquisition of a romiplostim biosimilar program referencing Nplate® from Enzene, strengthening its biosimilars portfolio and accelerating the company’s expansion into complex biological medicines.

From Adalvo 28 Oct 2026

Alcami announces promotion of Robert Tragas to Vice President, Laboratory Services

Alcami, a leading contract development and manufacturing organization (CDMO), today announced its strengthening of laboratory leadership with the promotion of Robert Tragas to Vice President, Laboratory Services.

28 Oct 2026

Prolific announces major new investments and partnerships with NantWorks and Zylidac Bio CDMO

On the heels of our exciting major investment and Nantworks partnership announcement last week, Prolific Machines is pleased to announce a great new partnership with Zylidac Bio, a fully integrated biologics CDMO located next door to us in San Francisco Bay Area, to scale up the production of Prolific's Optogentics-enabled cell lines for clinical and GMP manufacturing!

From Prolific Machines, Inc. 28 Oct 2026

NIOX® launches NIOX PRO®, their next generation FeNO testing device

NIOX Group plc, a global leader in fractional exhaled nitric oxide (FeNO) testing, has announced the launch of NIOX PRO®, its next-generation FeNO testing device designed to support healthcare professionals in the diagnosis and management of asthma, COPD and other inflammatory airway diseases.

From NIOX Group PLC 28 Oct 2026

Atelerix and Frontier Space partner to enable biological sample preservation for space missions

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced a partnership with Frontier Space, a UK based space biotechnology company building platform technology for in-orbit R&D and biomanufacturing.

From Atelerix Ltd 28 Oct 2026

Novel peptide from red alga shows potential for blood glucose control

It is a dietary staple found in sushi, rice wraps, and ramen toppings. Commonly known as nori in Japan and gim in Korea, red seaweed is especially popular across Asia.

27 Oct 2026

Climate change intensifies global health risks, Lancet Countdown report warns

The 2026 Report of the Lancet Countdown on Health and Climate Change finds that many of the health risks and harms of climate change grew faster in the decade since the Paris Agreement was introduced (2016–2025) than in the decade before it (2006–2015).

27 Oct 2026

UK study identifies ways to improve bowel cancer detection in IBD patients

The first UK-wide analysis of bowel screening for patients with inflammatory bowel disease (IBD) has identified opportunities to improve the early detection of cancer.

27 Oct 2026

One in four young Australians experienced physical abuse during childhood

New research shows one in four young people have experienced physical abuse in childhood at the hands of their parents - and most commonly before the age of ten.

27 Oct 2026

Pregnancy night shifts associated with higher risk of developmental abnormalities in children

Working night shifts during pregnancy is linked to a heightened risk of neurodevelopmental abnormalities detected by screening in the child by the age of 4, finds research published online in Occupational & Environmental Medicine.

27 Oct 2026

Autistic people report worse menopause symptoms and lower quality of life

A new study by researchers at Bournemouth University has shown that autistic people consistently experience more severe menopausal symptoms than non-autistic people, leading to poorer wellbeing and quality of life.

27 Oct 2026

Early neurological deterioration affects 30% of awake craniotomy patients

A retrospective study of 30 patients undergoing awake craniotomy found that 30% experienced new or worsened neurological dysfunction within 48-72 hours after surgery. Early functional and cognitive score reductions were common, while new-onset aphasia occurred in 10% of patients.

27 Oct 2026

A loneliness trial puts personalized nature-based support on the research agenda

In a randomized trial involving 320 adults experiencing loneliness, researchers found that loneliness scores declined in both a facilitated nature-based group program and an active signposting group, with no significant difference between them at three months. Neither approach significantly improved health-related quality of life, while exploratory analyses suggested that people with lower emotional wellbeing might benefit more from facilitated group activities.

27 Oct 2026

Low vitamin B12 is linked to heart disease. Supplements tell a different story

A narrative review published in Nutrition Journal examines how vitamin B12 deficiency may contribute to cardiovascular disease through elevated homocysteine, endothelial dysfunction, oxidative stress and altered methylation. The authors found that B12 supplementation has not consistently prevented heart attacks or cardiovascular deaths in clinical trials, although combined B-vitamin therapy may modestly reduce stroke risk, particularly in populations without folic acid fortification.

27 Oct 2026

Medical Research News

New score predicts thrombosis risk in hospitalized pancreatitis patients

Engineered albumin could lead to needle-free, long-lasting protein medicines

Plant and animal proteins show opposite effects on testosterone levels

Review highlights essential neurological considerations for gender dysphoria care

Overcoming cancer stigma requires policy changes and public education

DEBRA research invests in Topadur to advance small-molecule therapies for dystrophic Epidermolysis bullosa

Adalvo expands biosimilars portfolio through acquisition of romiplostim biosimilar program from Enzene

Alcami announces promotion of Robert Tragas to Vice President, Laboratory Services

Prolific announces major new investments and partnerships with NantWorks and Zylidac Bio CDMO

NIOX® launches NIOX PRO®, their next generation FeNO testing device

Atelerix and Frontier Space partner to enable biological sample preservation for space missions

Novel peptide from red alga shows potential for blood glucose control

Climate change intensifies global health risks, Lancet Countdown report warns

UK study identifies ways to improve bowel cancer detection in IBD patients

One in four young Australians experienced physical abuse during childhood

Pregnancy night shifts associated with higher risk of developmental abnormalities in children

Autistic people report worse menopause symptoms and lower quality of life

Early neurological deterioration affects 30% of awake craniotomy patients

A loneliness trial puts personalized nature-based support on the research agenda

Low vitamin B12 is linked to heart disease. Supplements tell a different story

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Latest News